GMABGENMAB A/Svs its industry peers
A metric-by-metric comparison of GENMAB A/S against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GMABEsta | — | — | — | — | — | — | — | — | — | — | — | — |
| VRTX | $121.4B#1 | 28.4x#1 | 6.3x#2 | 10.1x#1 | 8.9%#1 | 838.1%#1 | 34.8%#1 | 20.4%#1 | 25.4%#1 | — | 1.3%#1 | — |
| WAT | $38.9B#2 | 50.4x#2 | 2.5x#1 | 12.3x#2 | 7.0%#2 | 0.8%#2 | 25.4%#2 | 4.2%#2 | 3.5%#2 | 4#1 | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice